₹42,408.85
(118.75)(0.28%)
10 Jun , 2025 | 04:14 PM
Open
₹42,422.9
Prev. Close
₹42,290.1
Market Cap.
₹0
Div Yield
0
PE
0
PB
0
₹42,130
₹42,465.6
Performance
One Week (%)
2.22
One Month (%)
5.14
One Year (%)
20.98
YTD (%)
5.57
Company Name | CMP | High | Low | Volume |
---|---|---|---|---|
Abbott India Ltd | 31,645 | 32,100 | 31,550 | 3,041 |
Glaxosmithkline Pharmaceuticals Ltd | 3,398.4 | 3,450 | 3,346 | 1,12,904 |
J B Chemicals & Pharmaceuticals Ltd | 1,667.8 | 1,691.2 | 1,662.6 | 2,00,025 |
Pfizer Ltd | 5,773.5 | 5,809 | 5,621.5 | 53,195 |
Lupin Ltd | 2,004.8 | 2,017.6 | 1,987.8 | 7,33,750 |
Ipca Laboratories Ltd | 1,370.9 | 1,382.8 | 1,355.1 | 4,64,243 |
Neuland Laboratories Ltd | 12,674 | 12,855 | 12,606 | 23,626 |
Aurobindo Pharma Ltd | 1,170.9 | 1,172.5 | 1,152.5 | 5,64,177 |
Natco Pharma Ltd | 881.65 | 888.6 | 857.75 | 10,88,426 |
Granules India Ltd | 542.45 | 545 | 535 | 7,26,190 |
Ajanta Pharma Ltd | 2,576.3 | 2,601 | 2,564 | 46,819 |
Poly Medicure Ltd | 2,275.1 | 2,304 | 2,257.1 | 1,03,439 |
Gland Pharma Ltd | 1,664.7 | 1,667.3 | 1,645.1 | 1,42,370 |
Biocon Ltd | 341.2 | 348.15 | 339.55 | 60,67,297 |
Alkem Laboratories Ltd | 4,959 | 5,005 | 4,877 | 3,00,251 |
Glenmark Pharmaceuticals Ltd | 1,615.6 | 1,630 | 1,594.5 | 7,36,075 |
Max Healthcare Institute Ltd | 1,182.5 | 1,203.9 | 1,175.2 | 9,59,783 |
Fortis Healthcare Ltd | 778.9 | 781 | 758.3 | 13,69,394 |
Syngene International Ltd | 658.2 | 667 | 655 | 10,43,999 |
Global Health Ltd | 1,199.3 | 1,219 | 1,194 | 1,13,923 |
Krishna Institute of Medical Sciences Ltd | 650.65 | 653.7 | 634.95 | 4,33,061 |
Rainbow Childrens Medicare Ltd | 1,417.1 | 1,422.8 | 1,405.1 | 1,84,099 |
Mankind Pharma Ltd | 2,376.4 | 2,385 | 2,355.5 | 5,11,331 |
Alembic Pharmaceuticals Ltd | 982.7 | 994.7 | 978.3 | 37,436 |
Dr Lal Pathlabs Ltd | 2,960.1 | 2,973.6 | 2,832.1 | 2,06,160 |
Narayana Hrudayalaya Ltd | 1,813.9 | 1,822 | 1,791.5 | 2,68,613 |
Laurus Labs Ltd | 666.45 | 672.7 | 662.5 | 15,33,417 |
Aster DM Healthcare Ltd | 569.75 | 573.95 | 568.1 | 2,66,217 |
Cohance Lifesciences Ltd | 1,015 | 1,030.6 | 1,003.6 | 1,55,584 |
Piramal Pharma Ltd | 206.07 | 213.33 | 205.7 | 60,61,624 |
Despite the ban in the F&O segment, these stocks remain available for trading in the cash market. The NSE updates the list of securities in the F&O ban daily to reflect any changes.
7 Aug 2024|01:38 PM
Sector-wise, the Metal index emerged as a standout performer, witnessing a substantial 4% surge.
1 Mar 2024|03:40 PM
This revision applies to all Bank Nifty contracts, including weekly, monthly, and quarterly, shifting their expiry to Wednesdays
1 Mar 2024|09:57 AM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.